ARVN compared with IRWD: revenue, margins and what each company keeps, and the suppliers and customers both name

ARVNArvinas, Inc.

Mkt capRevenueRevenue

IRWDIronwood Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

ARVNArvinas, Inc.

IRWDIronwood Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ARVN 4

PFEPfizercustomer

NVSNovartis Pharmacustomer

—Yale Universityunlistedsupplier

—Bayerunlistedcustomer

Shared 0

No shared counterparties.

Only IRWD 8

ABBVAbbViesupplier

AZNAstraZeneca ABcustomer

—Ferringunlistedsupplier

—Cour

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlisted

supplier

4 more · IRWD chain ›

ARVNArvinas, Inc.

7.84▼−0.82%· post 7.84

Mkt cap$513.9MRevenue$250MQ2 FY26Revenue$263MFY25

IRWDIronwood Pharmaceuticals Inc

3.49▼−3.73%· post 3.49

ClosedOct 30 '26

Mkt cap$578.3MRevenue$113MQ2 FY26Revenue$296MFY25

Compare

ClosedOct 30 '26

ARVNArvinas, Inc.

IRWDIronwood Pharmaceuticals Inc

7.84▼−0.82%post 7.84

Price

3.49▼−3.73%post 3.49

$513.9M

Mkt cap

$578.3M

Q2 FY26$250M

Revenue

$113MQ2 FY26

FY25$263M

Revenue

$296MFY25

ARVN7.84▼−0.82%vsIRWD3.49▼−3.73%ClosedOct 30 '26